SCHEMBL17824282

SCHEMBL17824282

CN(C)CCNC(=O)Cn1c(NCc2ccccc2)nc2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.64
PKM P14618 1/20 0.64
RAB9A P51151 1/20 0.64
KMT2A Q03164 1/20 0.64
LMNA P02545 4/20 0.58
HTT P42858 2/20 0.58
TSHR P16473 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.54
ALDH1A1 P00352 5/20 0.53
MAPK1 P28482 2/20 0.50
POLB P06746 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
GAA P10253 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
MAPT P10636 1/20 0.49
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19713883 0.86 MEN1 (0.79) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL19714100 0.86 LMNA (0.73) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL19713983 0.86 MEN1 (0.65) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL17824312 0.85 RAB9A (0.64) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL19714135 0.83 RAB9A (0.61) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL19714637 0.83 RAB9A (0.61) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL19714188 0.83 RAB9A (0.61) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL17824292 0.83 MEN1 (0.64) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL17824280 0.82 LMNA (0.61) MEN1PKMRAB9AKMT2ALMNA
SCHEMBL17833386 0.82 LMNA (0.61) MEN1PKMRAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
EP-3230275-A1 PRO-SURVIVAL COMPOUNDS University Court of The University of Glasgow (GB) 2017-10-18 EP disclosed
WO-2016092327-A1 PRO-SURVIVAL COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2016-06-16 WO disclosed
WO-2016092327-A1 PRO-SURVIVAL COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS MCL1, MKI67, MORF4L1 MEN1 2331/4885PKM 3553/4885RAB9A 2097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.